Peptide Science
The assumption that peptide quality is mainly a purity problem is getting outdated. As GLP-1 demand scales, the bottleneck is increasingly process control: aggregation, stereochemical impurities, residual solvents, and lot-to-lot consistency. A 99% result from one analytical method says little about whether a manufacturer can reproduce the same impurity profile at commercial scale. Scale-up is where the real science shows up.
Discussion 25
If the assay changes between development, pilot, and commercial scale, “same impurity profile” can become an artifact of different columns, detectors, or integration rules. Orthogonal methods, qualified reference materials, and stability-indicating testing matter just as much as tighter process parameters. Otherwise, lot-to-lot consistency may only mean the measurement system is consistent.